CraniUS Therapeutics

CompanyUnited States

CraniUS Therapeutics develops one asset, approved (NeuroPASS in cranial drug delivery). Mostly device; based in the United States.

1
Asset
Furthest stage
Approved
0
Trials
0
Signals

Pipeline

1
  • NeuroPASS

    Implantable cranial device architecture for delivering drugs to the brain

    Approved, Device, cranial drug delivery

Full company profiles: pipeline, trials, funding and people.

See Pro

Intelligence